ASND | ASCENDIS PHARMA A/S - ADR | 15.33% | 10,107,400 | $1,273,027,030 | -612,155 | -5.71% | $125.95 | 13F |
IMGN | IMMUNOGEN INC | 8.48% | 23,750,601 | $704,205,320 | 10,428,313 | 78.28% | $29.65 | 13F |
JANX | Janux Therapeutics, Inc. | 6.08% | 10,593,395 | $451,384,561 | 1,427,743 | 15.58% | | 13D |
PCVX | VAXCYTE INC | 5.97% | 7,891,254 | $495,570,751 | | No Change | $62.8 | 13F |
LEGN | LEGEND BIOTECH CORP-ADR | 4.54% | 6,264,707 | $376,947,420 | | No Change | $60.17 | 13F |
RYTM | RHYTHM PHARMACEUTICALS INC | 2.95% | 5,330,412 | $245,039,040 | -345,655 | -6.09% | $45.97 | 13F |
TYRA | Tyra Biosciences, Inc. | 2.48% | 10,475,489 | $188,558,802 | 3,239,035 | 44.76% | | 13D |
ETNB | 89bio, Inc. | 2.36% | 12,766,948 | $195,972,652 | 1,350,000 | 11.82% | | Form 4 |
AVTE | AEROVATE THERAPEUTICS INC | 2.25% | 8,263,982 | $187,013,913 | | No Change | $22.63 | 13F |
INBX | INHIBRX INC | 2.16% | 4,724,207 | $179,519,866 | | No Change | $38 | 13F |
PEPG | PepGen Inc. | 2.15% | 10,695,135 | $151,657,014 | 2,563,183 | 31.52% | | 13D |
DYN | Dyne Therapeutics, Inc. | 2.00% | 5,213,661 | $135,868,006 | 5,213,661 | New | | 13G |
CBAY | CYMABAY THERAPEUTICS INC | 1.97% | 6,940,000 | $163,922,800 | | No Change | $23.62 | 13F |
BIIB | BIOGEN INC | 1.66% | 532,892 | $137,896,463 | | No Change | $258.77 | 13F |
RXST | RXSIGHT INC | 1.65% | 3,404,285 | $137,260,771 | 351,489 | 11.51% | $40.32 | 13F |
VRNA | VERONA PHARMA PLC - ADR | 1.51% | 6,317,990 | $125,601,641 | | No Change | $19.88 | 13F |
EWTX | Edgewise Therapeutics, Inc. | 1.48% | 8,909,091 | $116,174,547 | 8,909,091 | New | | 13G |
ANTX | AN2 THERAPEUTICS INC | 1.37% | 5,551,295 | $113,746,035 | | No Change | $20.49 | 13F |
DAWN | DAY ONE BIOPHARMACEUTICALS I | 1.37% | 7,809,852 | $114,023,839 | | No Change | $14.6 | 13F |
NKTX | Nkarta, Inc. | 1.33% | 10,805,129 | $108,051,290 | 3,000,000 | 38.44% | | Form 4 |
SPRY | ARS Pharmaceuticals, Inc. | 1.32% | 10,860,977 | $106,328,965 | 1,401,299 | 14.81% | | Form 4 |
ACRV | Acrivon Therapeutics, Inc. | 1.20% | 8,359,102 | $77,656,058 | 3,548,594 | 73.77% | | 13D |
LENZ | LENZ Therapeutics, Inc. | 1.20% | 6,564,674 | $98,667,050 | 6,564,674 | New | | Form 4 |
GERN | GERON CORP | 1.17% | 46,202,425 | $97,487,117 | | No Change | $2.11 | 13F |
ALPN | ALPINE IMMUNE SCIENCES INC | 1.13% | 4,909,763 | $93,580,083 | 218,585 | 4.66% | $19.06 | 13F |
WVE | WAVE LIFE SCIENCES LTD | 1.11% | 18,202,009 | $91,920,145 | 1,000,000 | 5.81% | $5.05 | 13F |
NAMS | NEWAMSTERDAM PHARMA CO NV | 1.06% | 7,864,000 | $87,840,880 | -1,136,000 | -12.62% | $11.17 | 13F |
LRMR | Larimar Therapeutics, Inc. | 1.03% | 6,045,351 | $77,259,586 | 6,045,351 | New | | 13G |
FDMT | 4D MOLECULAR THERAPEUTICS IN | 1.02% | 4,163,211 | $84,346,655 | | No Change | $20.26 | 13F |
EVH | EVOLENT HEALTH INC - A | 1.01% | 2,549,132 | $84,197,830 | -187,548 | -6.85% | $33.03 | 13F |
MLYS | Mineralys Therapeutics, Inc. | 0.97% | 4,949,307 | $72,853,799 | 1,770,831 | 55.71% | | 13D |
AXSM | AXSOME THERAPEUTICS INC | 0.96% | 1,000,000 | $79,590,000 | | No Change | $79.59 | 13F |
LBPH | Longboard Pharmaceuticals, Inc. | 0.96% | 3,073,119 | $77,135,287 | 3,073,119 | New | | 13G |
FULC | FULCRUM THERAPEUTICS INC | 0.94% | 11,609,704 | $78,365,502 | | No Change | $6.75 | 13F |
ATXS | Astria Therapeutics, Inc. | 0.78% | 4,413,150 | $59,842,314 | 4,413,150 | New | | 13G |
CTKB | CYTEK BIOSCIENCES INC | 0.75% | 6,809,404 | $62,101,764 | | No Change | $9.12 | 13F |
ABOS | ACUMEN PHARMACEUTICALS INC | 0.69% | 14,932,063 | $57,339,122 | | No Change | $3.84 | 13F |
APGE | APOGEE THERAPEUTICS INC | 0.67% | 1,977,901 | $55,262,554 | | No Change | $27.94 | 13F |
DNTH | Dianthus Therapeutics, Inc. /DE/ | 0.63% | 2,995,023 | $49,118,377 | 2,995,023 | New | | 13G |
VOR | VOR BIOPHARMA INC | 0.62% | 22,748,880 | $51,184,980 | | No Change | $2.25 | 13F |
ITOS | ITEOS THERAPEUTICS INC | 0.58% | 4,417,259 | $48,368,986 | | No Change | $10.95 | 13F |
MDGL | MADRIGAL PHARMACEUTICALS INC | 0.57% | 204,500 | $47,317,210 | | No Change | $231.38 | 13F |
URGN | UROGEN PHARMA LTD | 0.56% | 3,083,430 | $46,251,450 | 1,599,733 | 107.82% | $15 | 13F |
ELYM | Eliem Therapeutics, Inc. | 0.55% | 13,189,736 | $35,216,595 | 38,887 | 0.30% | | 13D |
HOWL | Werewolf Therapeutics, Inc. | 0.51% | 6,179,035 | $37,815,694 | 34,154 | 0.56% | | 13D |
MGNX | MACROGENICS INC | 0.47% | 4,053,077 | $38,990,601 | 3,711,077 | 1085.11% | $9.62 | 13F |
SLDB | Solid Biosciences Inc. | 0.42% | 4,348,828 | $33,485,976 | 4,348,828 | New | | 13D |
TSHA | TAYSHA GENE THERAPIES INC | 0.39% | 18,472,503 | $32,696,330 | | No Change | $1.77 | 13F |
GHRS | GH RESEARCH PLC | 0.39% | 5,587,333 | $32,406,531 | | No Change | $5.8 | 13F |
BOLD | Boundless Bio, Inc. | 0.38% | 1,884,787 | $30,156,592 | 1,884,787 | New | | Form 4 |
CYBN | CYBIN INC. | 0.36% | 58,139,535 | $25,000,000 | 58,139,535 | New | | 13G |
ELVN | ENLIVEN THERAPEUTICS INC | 0.35% | 2,122,465 | $29,374,916 | | No Change | $13.84 | 13F |
CCCC | C4 THERAPEUTICS INC | 0.33% | 4,878,000 | $27,560,700 | 4,878,000 | New | $5.65 | 13F |
ANRO | Alto Neuroscience, Inc. | 0.29% | 1,385,491 | $19,992,635 | 1,385,491 | New | | 13G |
CRVO | CervoMed Inc. | 0.29% | 825,373 | $18,735,967 | 825,373 | New | | 13G |
SLDB | Solid Biosciences Inc. | 0.29% | 4,301,877 | $23,789,380 | 875,591 | 25.56% | | Form 4 |
PLRX | PLIANT THERAPEUTICS INC | 0.28% | 1,281,000 | $23,198,910 | -481,000 | -27.3% | $18.11 | 13F |
RNA | AVIDITY BIOSCIENCES INC | 0.27% | 2,454,533 | $22,213,524 | -3,962,465 | -61.75% | $9.05 | 13F |
SERA | SERA PROGNOSTICS, INC. | 0.27% | 2,047,221 | $18,465,933 | 2,047,221 | New | | 13G |
THRD | THIRD HARMONIC BIO INC | 0.27% | 2,033,056 | $22,302,624 | 1,071,193 | 111.37% | $10.97 | 13F |
ACET | Adicet Bio, Inc. | 0.25% | 7,696,949 | $19,011,464 | 7,696,949 | New | | 13G |
GPCR | STRUCTURE THERAPEUTICS INC | 0.24% | 486,832 | $19,843,272 | 486,832 | New | $40.76 | 13F |
RGLS | Regulus Therapeutics Inc. | 0.22% | 6,250,000 | $15,312,500 | 6,250,000 | New | | 13G |
ARVN | ARVINAS INC | 0.21% | 421,348 | $17,342,684 | 421,348 | New | $41.16 | 13F |
HARP | HARPOON THERAPEUTICS INC | 0.21% | 1,500,000 | $17,055,000 | 1,500,000 | New | $11.37 | 13F |
TNYA | TENAYA THERAPEUTICS INC | 0.21% | 5,507,347 | $17,843,804 | -1,211,136 | -18.03% | $3.24 | 13F |
BCYC | BICYCLE THERAPEUTICS PLC-ADR | 0.17% | 800,000 | $14,464,000 | | No Change | $18.08 | 13F |
CRBP | Corbus Pharmaceuticals Holdings, Inc. | 0.15% | 430,182 | $11,494,463 | 430,182 | New | | 13G |
VXRT | Vaxart, Inc. | 0.15% | 15,384,615 | $12,153,846 | 15,384,615 | New | | 13G |
CMPS | COMPASS PATHWAYS PLC | 0.14% | 1,286,000 | $11,252,500 | | No Change | $8.75 | 13F |
CVAC | CUREVAC NV | 0.14% | 2,744,270 | $11,553,377 | -7,860,074 | -74.12% | $4.21 | 13F |
BDTX | BLACK DIAMOND THERAPEUTICS I | 0.12% | 3,525,754 | $9,907,369 | | No Change | $2.81 | 13F |
CMRX | CHIMERIX INC | 0.10% | 8,800,000 | $8,470,000 | 2,298,376 | 35.35% | $0.96 | 13F |
IGMS | IGM BIOSCIENCES INC | 0.09% | 937,500 | $7,790,625 | | No Change | $8.31 | 13F |
SRZN | Surrozen, Inc./DE | 0.06% | 323,662 | $3,667,090 | 323,662 | New | | 13G |
UNCY | UNICYCIVE THERAPEUTICS INC | 0.04% | 3,470,688 | $3,011,516 | | No Change | $0.87 | 13F |
SABS | SAB BIOTHERAPEUTICS INC | 0.02% | 2,374,081 | $1,632,181 | 2,374,081 | New | $0.69 | 13F |
NAMSW | NEWAMSTERDAM PHARMA CO NV-27 | 0.01% | 333,333 | $1,043,332 | | No Change | $3.13 | 13F |
ACRS | ACLARIS THERAPEUTICS INC | | | | -4,398,453 | Exited | | 13F |
CELC | CELCUITY INC | | | | -1,400,001 | Exited | | 13F |
COGT | COGENT BIOSCIENCES INC | | | | -6,416,147 | Exited | | 13F |
CNTB | Connect Biopharma Holdings Ltd | | | | -3,062,871 | Exited | | 13D |
EYPT | EYEPOINT PHARMACEUTICALS INC | | | | -3,370,506 | Exited | | 13F |
ICVX | Icosavax, Inc. | | | | -5,963,565 | Exited | | 13D |
NSTG | NANOSTRING TECHNOLOGIES INC | | | | -1,723,373 | Exited | | 13F |
NKTR | NEKTAR THERAPEUTICS | | | | -18,700,000 | Exited | | 13F |
SLNO | SOLENO THERAPEUTICS INC | | | | -1,239,000 | Exited | | 13F |
TALS | TALARIS THERAPEUTICS INC | | | | -2,403,238 | Exited | | 13F |
VRDN | VIRIDIAN THERAPEUTICS INC | | | | -2,007,946 | Exited | | 13F |